Mike Kratky
Stock Analyst at Leerink Partners
(2.92)
# 1,025
Out of 5,182 analysts
42
Total ratings
32%
Success rate
16.76%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $622 → $573 | $452.35 | +26.67% | 2 | Apr 22, 2026 | |
| BBNX Beta Bionics | Maintains: Outperform | $25 → $24 | $10.22 | +134.83% | 2 | Apr 22, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiates: Market Perform | $101 | $82.67 | +22.17% | 1 | Apr 13, 2026 | |
| SYK Stryker | Initiates: Outperform | $410 | $290.88 | +40.95% | 1 | Apr 13, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Outperform | $55 → $30 | $24.83 | +20.82% | 2 | Feb 26, 2026 | |
| PODD Insulet | Maintains: Outperform | $386 → $360 | $171.39 | +110.05% | 2 | Feb 19, 2026 | |
| TXG 10x Genomics | Maintains: Market Perform | $22 → $20 | $21.65 | -7.62% | 5 | Jan 27, 2026 | |
| PEN Penumbra | Downgrades: Market Perform | $374 | $324.65 | +15.20% | 2 | Jan 16, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $127 → $128 | $56.85 | +125.15% | 2 | Oct 1, 2025 | |
| INSP Inspire Medical Systems | Maintains: Market Perform | $116 → $97 | $54.84 | +76.88% | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $110 | $78.30 | +40.49% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $87 | $60.04 | +44.90% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $45 | $19.87 | +126.47% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $16.90 | +30.18% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $42 | $36.46 | +15.21% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $75 | $83.33 | -10.00% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $9 | $42.63 | -78.89% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $45 | $1.19 | +3,681.51% | 2 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $315 | $518.66 | -39.27% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $26 → $31 | $83.59 | -62.91% | 2 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $27.85 | -49.73% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $14.06 | +184.50% | 1 | Aug 15, 2022 |
Intuitive Surgical
Apr 22, 2026
Maintains: Outperform
Price Target: $622 → $573
Current: $452.35
Upside: +26.67%
Beta Bionics
Apr 22, 2026
Maintains: Outperform
Price Target: $25 → $24
Current: $10.22
Upside: +134.83%
Zimmer Biomet Holdings
Apr 13, 2026
Initiates: Market Perform
Price Target: $101
Current: $82.67
Upside: +22.17%
Stryker
Apr 13, 2026
Initiates: Outperform
Price Target: $410
Current: $290.88
Upside: +40.95%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Outperform
Price Target: $55 → $30
Current: $24.83
Upside: +20.82%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $386 → $360
Current: $171.39
Upside: +110.05%
10x Genomics
Jan 27, 2026
Maintains: Market Perform
Price Target: $22 → $20
Current: $21.65
Upside: -7.62%
Penumbra
Jan 16, 2026
Downgrades: Market Perform
Price Target: $374
Current: $324.65
Upside: +15.20%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $127 → $128
Current: $56.85
Upside: +125.15%
Inspire Medical Systems
Aug 15, 2025
Maintains: Market Perform
Price Target: $116 → $97
Current: $54.84
Upside: +76.88%
Jun 16, 2025
Initiates: Outperform
Price Target: $110
Current: $78.30
Upside: +40.49%
Oct 25, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $60.04
Upside: +44.90%
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $19.87
Upside: +126.47%
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $16.90
Upside: +30.18%
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $36.46
Upside: +15.21%
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $83.33
Upside: -10.00%
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $42.63
Upside: -78.89%
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $1.19
Upside: +3,681.51%
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $518.66
Upside: -39.27%
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $83.59
Upside: -62.91%
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $27.85
Upside: -49.73%
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $14.06
Upside: +184.50%